Search results
Results from the WOW.Com Content Network
Since these lesions do not have malignant potential, long-term observation with imaging surveillance is unnecessary. [4] Surgery can include the removal of the head of the pancreas (a pancreaticoduodenectomy), removal of the body and tail of the pancreas (a distal pancreatectomy), or rarely removal of the entire pancreas (a total pancreatectomy ...
They do not communicate with the pancreatic ducts and they usually present as single, thick walled, non-loculated (having a single chamber) lesions. They characteristically contain ovarian type stromal cells. [1] Pancreatic neuroendocrine tumors may sometimes undergo cystic degeneration forming
Pancreatic mucinous cystic neoplasm (MCN) is a type of cystic lesion that occurs in the pancreas. Amongst individuals undergoing surgical resection of a pancreatic cyst, about 23 percent were mucinous cystic neoplasms. These lesions are benign, though there is a high rate of progression to cancer. As such, surgery should be pursued when feasible.
sunitinib (Sutent) is labeled for treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease. [ 27 ] [ 28 ] Sutent also has approval from the European Commission for the treatment of 'unresectable or metastatic, well-differentiated pancreatic neuroendocrine ...
Pancreatic endocrine tumors are named after the type of hormone they release. For example, an insulin-secreting tumor is referred to as an "insulinoma". On the other end of the spectrum, non-functioning types of endocrine tumors do not secrete hormones and thus do not give rise to obvious clinical symptoms.
Cystic lesions of the pancreas are a group of pancreatic lesions characterized by a cystic appearance. They can be benign or malignant. [citation needed] Cystic lesions are found in 20.6% of all pancreatectomy specimens. Among this heterogeneous group, benign neoplasms predominate, particularly those with mucinous lining.
Gastrinomas are located predominantly in the duodenum (70%) and pancreas (25%). [20] Pancreatic gastrinomas are larger than their duodenal counterparts, may occur in any portion of the pancreas, and comprise 25% of these tumors. Gastrinomas are also the most common functional and malignant pancreatic endocrine tumors. [21]
For this reason, benign tumors are not classed as cancer. [27] Benign tumors will grow in a contained area usually encapsulated in a fibrous connective tissue capsule. The growth rates of benign and malignant tumors also differ; benign tumors generally grow more slowly than malignant tumors.